UROGEN PHARMA LTD shareholders Q3 2023

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
China Universal Asset Management Co., Ltd. 774$110.00%
Point72 Middle East FZE 5,941$83,2380.00%
Verition Fund Management LLC 17,017$238,4080.00%
West Tower Group, LLC 354$4,9600.00%
Connor, Clark & Lunn Investment Management Ltd. 29,766$417,0220.00%
Carmel Capital Partners, LLC 259$3,6290.00%
MILLENNIUM MANAGEMENT LLC 275,785$3,863,7480.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 12,659$5940.00%
MetLife Investment Management, LLC 10,403$145,7460.00%
Ameritas Investment Partners, Inc. 1,616$22,6400.00%
MARSHALL WACE, LLP 26,821$375,7620.00%
AMERICAN INTERNATIONAL GROUP, INC. 9,765$136,8080.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,078$15,1030.00%
TWO SIGMA ADVISERS, LP 18,900$264,7890.00%
WELLS FARGO & COMPANY/MN 216,533$3,033,6120.00%
Cresset Asset Management, LLC 16,716$234,1910.00%
WELLINGTON MANAGEMENT GROUP LLP 70,063$981,5820.00%
Invesco Ltd. 10,055$140,8710.00%
ACADIAN ASSET MANAGEMENT LLC 4,563$630.00%
Nuveen Asset Management, LLC 63,634$891,5120.00%
External links

This page lists UROGEN PHARMA LTD's shareholders in Q3 2023. To view UROGEN PHARMA LTD's shareholder history, click here.